Compugen Ltd. (CGEN)

Compugen Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	-	33.46	7.5	6	2	0
Revenue Growth (YoY)	-	346.12%	25.00%	200.00%	-	-
Cost of Revenue	-	2	0.98	0.68	0.06	0
Gross Profit	-	31.46	6.53	5.32	1.94	0
Selling, General & Admin	-	9.98	11.25	11.7	10.68	9.06
Research & Development	-	34.47	30.65	28.69	22.76	19.82
Operating Expenses	-	44.45	41.9	40.39	33.44	28.88
Operating Income	-	-12.99	-35.37	-35.07	-31.5	-28.88
Other Expense / Income	-	-3.21	-1.74	-0.87	-1.8	-0.82
Pretax Income	-	-9.78	-33.64	-34.2	-29.7	-28.06
Income Tax	-	8.97	0.06	0	0	-0.72
Net Income	-	-18.75	-33.69	-34.2	-29.7	-27.34
Shares Outstanding (Basic)	90	88	87	84	80	64
Shares Outstanding (Diluted)	-	88	87	84	80	64
Shares Change	3.41%	1.25%	2.79%	5.80%	25.07%	15.12%
EPS (Basic)	-	-0.21	-0.39	-0.41	-0.37	-0.43
EPS (Diluted)	-	-0.21	-0.39	-0.41	-0.37	-0.43
Free Cash Flow	-	-36.06	-34.6	-22.98	-28.44	-27.66
Free Cash Flow Per Share	-	-0.41	-0.40	-0.27	-0.36	-0.43
Gross Margin	-	94.01%	87.00%	88.67%	97.00%	-
Operating Margin	-	-38.83%	-471.65%	-584.57%	-1574.80%	-
Profit Margin	-	-56.05%	-449.25%	-570.05%	-1484.90%	-
Free Cash Flow Margin	-	-107.77%	-461.31%	-383.00%	-1422.10%	-
EBITDA	-	-9.31	-33.15	-33.74	-28.98	-27.07
EBITDA Margin	-	-27.82%	-442.05%	-562.37%	-1449.15%	-
Depreciation & Amortization	-	0.48	0.48	0.46	0.72	0.99
EBIT	-	-9.78	-33.64	-34.2	-29.7	-28.06
EBIT Margin	-	-29.24%	-448.48%	-570.05%	-1484.90%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).